Alternatives to Pixelgen Technologies

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Developing oral small molecule medicines for immunological and chronic diseases.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

AI-enabled technology for cell biology research and biopharma development.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Biopharmaceutical company developing T-cell therapies for solid tumor cancers.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Developer of spatial biology tools for life sciences research, now part of Bruker Spatial Biology.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Global supplier of life science research tools, including antibodies, reagents, and assays.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

AI-powered knowledge discovery for life sciences.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Revolutionizing genomic analysis with innovative sequencing technology.

Pioneering vision restoration therapies for severe retinal degenerations.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing novel therapies to reverse aging and extend lifespan.

Advancing next-generation mRNA medicines.

A full-stack spatial biology company.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Immunotherapy company targeting oncology and autoimmune diseases.

A biotechnology company focused on oncology drug discovery.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Scalable, one-time curative in-vivo gene editing therapies.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.

Advancing targeted alpha therapies.

Platform designed to cut cell and gene therapy production costs.

Develops and distributes bioreactor technology for stem cell cultivation.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.